Potency is often measured through preclinical and clinical trials. In preclinical studies, the effectiveness of a treatment is evaluated using cell lines or animal models. Clinically, potency is assessed by observing the response rates, tumor shrinkage, and survival rates in patients. The IC50 value—the concentration of a drug needed to inhibit cell growth by 50%—is a common metric used to quantify potency.
